These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2199037)

  • 1. Possible mechanism of antidepressant effect of L-sulpiride.
    Serra G; Forgione A; D'Aquila PS; Collu M; Fratta W; Gessa GL
    Clin Neuropharmacol; 1990; 13 Suppl 1():S76-83. PubMed ID: 2199037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
    Sigala S; Rizzonelli P; Zanelli E; Forgione A; Missale C; Spano P
    Eur J Pharmacol; 1991 Jun; 199(2):247-53. PubMed ID: 1683290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of sulpiride--a dopamine receptor antagonist.
    O'Connor SE; Brown RA
    Gen Pharmacol; 1982; 13(3):185-93. PubMed ID: 7047291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives.
    Lombardi C; De Cotiis R; Spedini C; Missale C; Memo M; Spano PF
    Eur J Clin Pharmacol; 1987; 33(5):519-21. PubMed ID: 2962878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity.
    Diana M; Muntoni AL; Pistis M; Collu M; Forgione A; Gessa GL
    Eur J Pharmacol; 1996 Sep; 312(2):179-81. PubMed ID: 8894593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of sulpiride as an atypical antidepressant agent.
    Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1982; 32():85-103. PubMed ID: 7046370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments.
    Willner P
    Brain Res; 1983 Dec; 287(3):237-46. PubMed ID: 6318882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic effects of sulpiride--racemic and enantiomers--on renal response to low-dose dopamine infusion in normal women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P
    Nephron; 1989; 51(4):491-8. PubMed ID: 2739826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stereospecificity of hypothalamo-hypophysial dopamine receptors involved in the control of prolactin secretion in normal man: effects of sulpiride stereoisomers].
    Benfenati F; De Camillis E; Cortelli P; Orlandi F
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1226-32. PubMed ID: 7459063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
    Kendler KS; Bracha HS; Davis KL
    Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical basis of antidepressant effect of low dose of sulpiride.
    Kaneno S; Komatsu H; Fukamauchi F; Ikawa K; Watanabe A
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):131-2. PubMed ID: 1836504
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.
    Van den Buuse M; Jones CR; Wagner J
    Brain Res Bull; 1992 Feb; 28(2):289-97. PubMed ID: 1375862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in peripheral and central dopamine receptor sensitivity after subchronic treatment with fluphenazine and sulpiride.
    Hietala J; MacDonald E; Syvälahti E; Scheinin M
    Pharmacol Toxicol; 1987 Jul; 61(1):48-52. PubMed ID: 3628181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.
    Nörenberg W; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):151-60. PubMed ID: 2572971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.